Cargando…

Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease

OBJECTIVE: To develop group-based trajectories of depressive symptoms in immune-mediated inflammatory disease (IMID) to understand their evolution and identify any associated factors, with the overall goal of identifying those at highest risk of higher depressive symptom burden. METHOD: 922 particip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalec, Kaarina, Salter, Amber, Fitzgerald, Kathryn C., Patel, Mitulkumar, Han, Jing, Lu, Yi, Bolton, James M., Hitchon, Carol, Bernstein, Charles N., Patten, Scott, Graff, Lesley A., Marriott, James J., Marrie, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724746/ https://www.ncbi.nlm.nih.gov/pubmed/35461162 http://dx.doi.org/10.1016/j.genhosppsych.2022.04.005

Ejemplares similares

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis
por: Kowalec, Kaarina, et al.
Publicado: (2021)

Polygenicity of Comorbid Depression in Multiple Sclerosis
por: Kowalec, Kaarina, et al.
Publicado: (2023)

Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease
por: Carney, Heather, et al.
Publicado: (2020)

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
por: Vasileiou, Eleni S., et al.
Publicado: (2022)

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study
por: Almweisheer, Shaza, et al.
Publicado: (2023)

Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis
por: Jain, Dhruv, et al.
Publicado: (2023)

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Within-person fluctuations over three years in depression, anxiety, fatigue, and health-related quality of life in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis
por: Hitchon, Carol A., et al.
Publicado: (2020)

Systematic Review and Meta-analysis of Interventions for Depression and Anxiety in Persons With Rheumatoid Arthritis
por: Fiest, Kirsten M., et al.
Publicado: (2017)

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
por: Fiest, Kirsten M., et al.
Publicado: (2016)

Effect of mood and anxiety disorders on health care utilization in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2020)

Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Prescription opioid use in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Impact of Psychiatric Comorbidity on Health Care Use in Rheumatoid Arthritis: A Population‐Based Study
por: Hitchon, Carol A., et al.
Publicado: (2020)

Polygenic risk scores of lithium response and treatment resistance in major depressive disorder
por: Xiong, Ying, et al.
Publicado: (2023)

Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease
por: Patel, Ronak, et al.
Publicado: (2023)

Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review
por: Jain, Avni, et al.
Publicado: (2019)

Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure
por: Marrie, Ruth Ann, et al.
Publicado: (2022)

Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed
por: Carter, Sean L., et al.
Publicado: (2023)

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases
por: Enns, Murray W., et al.
Publicado: (2018)

Physical and Mental Health–Related Quality of Life Trajectories Among People With Multiple Sclerosis
por: O'Mahony, Julia, et al.
Publicado: (2022)

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2017)

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Polygenic risk score for Alzheimer’s disease and trajectories of cardiometabolic risk factors in children
por: Korologou-Linden, Roxanna, et al.
Publicado: (2019)

Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study
por: Bernstein, Charles N., et al.
Publicado: (2015)

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case–control study protocol for dimethyl fumarate-induced lymphopenia
por: Kowalec, Kaarina, et al.
Publicado: (2017)

Associations of polygenic risk scores with posttraumatic stress symptom trajectories following combat deployment
por: Campbell-Sills, Laura, et al.
Publicado: (2023)

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study
por: Hitchon, Carol A, et al.
Publicado: (2023)

Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases
por: Blaney, C., et al.
Publicado: (2020)

Association of polygenic risk scores and hair cortisol with mental health trajectories during COVID lockdown
por: Ahrens, Kira F., et al.
Publicado: (2022)

Headaches and polygenic scores
por: Vilhjálmsson, Bjarni J., et al.
Publicado: (2019)

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog
por: Hingorani, Aroon D, et al.
Publicado: (2023)

Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences
por: Rosenberg, Noah A, et al.
Publicado: (2018)

Polygenic risk scores to stratify cancer screening should predict mortality not incidence
por: Vickers, Andrew J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nquqbm5gc513fp0heam0po4v64